ESC 365 - BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension

ESC2025 Premium Access

BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension

Session: HOT LINE 4

Topic: Pharmacotherapy

Speaker: Professor B. Williams (London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Professor Bryan Williams

University College London, London (United Kingdom of Great Britain & Northern Ireland)

75 presentations

10 followers

11 more presentations in this session

Discussant review - BaxHTN

Speaker: Professor T. Guzik (Edinburgh, GB)

Panel discussion - BaxHTN

KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk

Speaker: Doctor N. Pagidipati (Durham, US)

Discussant review - KARDIA-3

Speaker: Professor M. Tomaszewski (Manchester, GB)

Panel discussion - KARDIA-3

Access the full session

HOT LINE 4

Speakers: Professor B. Williams, Professor T. Guzik, Doctor N. Pagidipati, Professor M. Tomaszewski

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources